适体市场-全球行业规模、份额、趋势、机会和预测，2018-2028 按类型、技术、应用、最终用户、地区和竞争分析

在 2024 年至 2028 年的预测期内，全球适体市场预计将以稳定的复合年增长率增长。 这可能是由于製药和生物技术行业增加了对研发的投资。 此外，预计在预测期内，对高效和低成本适配体的需求不断增长将带来利润丰厚的增长。 同样，用于治疗罕见疾病的新型疗法的持续开发也将推动适体市场的长期增长。 同样，人们越来越意识到适体相对于抗体的优势，例如热稳定性、减少生产时间和具有成本效益的合成，将进一步推动市场增长。 此外，适体可以针对更广泛的分子，这进一步推动了全球适体市场的增长。 近年来，越来越多的新适体获得批准也是推动市场增长的主要因素之一。

在工业中的使用增加

多年来，适体已成功用于病原体识别、癌症识别和环境污染监测。 此外，适体也被用作干细胞标记物。 环境污染意识的增强和减少环境污染的需求预计将支持全球适体市场的增长。 此外，癌症、心血管疾病、神经退行性疾□□病和获得性免疫缺陷综合症等危及生命的疾病日益流行是推动对基于适体疗法的新型有效检测方法需求的主要因素。预计将进一步推动增长预测期内的市场。 根据世界癌症观察站的数据，2020 年全球将报告约 19,292,789 例新癌症病例，其中乳腺癌、肺癌、结肠癌、前列腺癌和胃癌是最常见的类型。 由于适配体在癌症意识中的使用越来越多，以及为开发各种治疗方法而进行的临床试验数量不断增加，预计未来几年对适配体的需求将会增长。 预计在预测期内，为改进诊断设备和药物及其载体而进行的不断增加的研发活动也将增加对适体市场的需求。 此外，民间组织正在与学术机构和研究机构合作开发下一代产品并扩大市场。 同样，食品和饮料行业应用的增加预计将在预测期内推动市场增长。

适体意识的增强

多年来，适体在各行各业的使用不断增加以及与适体相关的技术创新推动了市场的增长。 适体也是单链 DNA 或 RNA 分子，可以选择性地结合特定靶标，与单克隆抗体相比具有许多优势，预计到 2028 年将推动市场增长。 这些分子结合蛋白质、□、小分子、毒素、碳水化合物甚至活细胞等靶标。 它们可以通过从大型随机序列池中进行选择的过程生成，并且可以用于临床和研究目的。

慢性病和罕见病患病率上升

罕见疾病的日益流行需要具有先进特定功能的新疗法来对抗病毒，预计这将在预测期内推动对适体的需求。 同样，技术的不断进步有望推动市场的增长。 根据 2022 年 4 月发表在 Electrochimica Acta Journal 上的美国医疗保健机构的一项调查结果，适体具有诊断、药物输送、治疗剂和药物分析等多种用途，有望用作仿生分子识别元素，竟然在医学界备受瞩目。 此外，用于检测癌症和其他疾病的新试剂盒的开发将在预测期内增加对适体的需求。

近期发展

• 2021 年 3 月，Optimer 试剂的开发商 Aptamer Group 宣布与 Mologic 合併，Mologic 是侧流和快速诊断检测试剂盒的製造商。 进行合併的目的是生产新型冠状病毒 SARS-CoV-2 的检测试剂盒。
• 2020 年 5 月，Portage Biotech 在获得概念验证后对 Saugatuck 疗法进行了追加投资。 这启动了下一笔 700,000 美元的注资。 Saugatuck 已经表明，其专有的 PD1 适体可以配製成 NLG 製剂，并且该製剂可以适当地调节 PD1 信号。

可自定义

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

• 对其他市场参与者（最多 5 家公司）进行深入分析和概况分析。

内容

第 1 章概述

• 市场定义
• 市场范围
  • 目标市场
  • 研究目标年份
  • 主要市场细分

第二章研究方法论

• 调查目的
• 基线调查方法
• 主要行业合作伙伴
• 主要协会和次要信息
• 调查方法
• 数据三角测量和验证
• 假设和限制

第 3 章执行摘要

• 市场概览
• 主要市场细分概述
• 主要市场参与者概览
• 主要地区/国家概览
• 市场驱动因素、挑战和趋势

第 4 章 VOC（客户之声）

第五章适体全球市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（DNA 适体、XNA 适体、RNA 适体）
  • 通过技术（SELEX、其他）
  • 按应用（治疗药物开发、R&D、诊断药物等）
  • 最终用户（製药公司、生物技术公司、学术/研究机构、合同研究机构等）
  • 按地区（北美、欧洲、亚太地区、南美、中东/非洲）
  • 按公司分类（2022 年）
• 市场地图
  • 按类型
  • 按技术
  • 通过申请
  • 最终用户
  • 按地区

第六章北美适体市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型
  • 按技术
  • 通过申请
  • 最终用户
  • 按国家
• 北美：国家/地区分析
  • 美国
  • 加拿大
  • 墨西哥

第 7 章：欧洲适体市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型
  • 按技术
  • 通过申请
  • 最终用户
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第八章亚太适体市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型
  • 按技术
  • 通过申请
  • 最终用户
  • 按国家
• 亚太地区：国家/地区分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第9章南美适体市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型
  • 按技术
  • 通过申请
  • 最终用户
  • 按国家
• 南美洲：：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章中东和非洲适体市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型
  • 按技术
  • 通过申请
  • 最终用户
  • 按国家
• MEA：国家分析
  • 南非适体
  • 沙特阿拉伯适体
  • 阿联酋适体

第 11 章市场动态

• 司机
• 做

第12章市场趋势与发展

• 近期发展状况
• 併购
• 产品发布

第 13 章全球适体市场：SWOT 分析

第 14 章波特的五力分析

• 行业竞争
• 新进入的可能性
• 供应商的力量
• 客户力量
• 替代品的威胁

第15章竞争格局

• 业务概览
• 提供的产品
• 近期发展状况
• 财务（据报导）
• 主要人物
• SWOT 分析
  • Aptamer Group
  • Raptamer Discovery Group
  • Somalogic Inc.
  • Aptamer Sciences, Inc.
  • Aptagen LLC.
  • Maravai Lifesciences.
  • Kaneka Corporation.
  • Neoventures Biotechnology Inc.
  • Aptus Biotech.
  • Base Pair Biotechnologies.

第 16 章战略建议

Global Aptamers market is anticipated to witness a growth of steady CAGR in the forecast period, 2024-2028. This can be ascribed to the increasing investments in the research and development sector by the pharmaceutical and biotechnology industries. Also, the growing demand for high-efficiency and low-cost aptamers is expected to create lucrative growth during the forecasted period. Similarly, the growing development of novel therapies for the treatment of rare diseases will drive the growth of the aptamers market over the years. Similarly, rising awareness of the advantages of aptamers, such as their thermal stability, shorter production time, and cost-effective synthesis, among others, over antibodies will further boost the growth of the market. Additionally, aptamers can target a wider spectrum of molecules, which further drives the growth of the global aptamer market. Increasing approvals of novel aptamers are also one of the major factors driving the growth of the market over the last few years.

Increasing Use Across Industries

Aptamers have been successfully used over the years for pathogen recognition, cancer recognition, and monitoring environmental contamination, among others. Additionally, aptamers are also used as stem cell markers. The growing awareness about environmental pollution and the need to reduce environmental contamination is expected to support the growth of the global aptamers market. Besides, the increasing prevalence of life-threatening diseases such as cancer, cardiovascular diseases, neurodegenerative diseases, and acquired immunodeficiency syndrome are the major factors enhancing the demand for new and effective detection assays based on aptamer therapy which will further boost the growth of the market during the forecasted period. According to the global cancer observatory, around 19,292,789 new cancer cases were reported worldwide in 2020, with Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer, and Stomach Cancer being the most prevalent types. The increasing use of aptamers in cancer recognition and the increasing number of clinical trials being conducted for the development of different treatments are expected to increase the demand for aptamers in the coming years. Also, growing research and development activities for improving diagnostic devices and drugs and their carriers will enhance the demand for the aptamers market in the forecasted period. Also, private organizations are collaborating with academic institutes and research laboratories to develop next-generation products and expand their market. Similarly, growing application in the food and beverage industry is anticipated to boost the growth of the market in the forecasted period.

Growing Awareness About Aptamers

The growing usage of aptamers by different industries and innovations happening related to aptamers has encouraged market growth over the years. Also, growing awareness among the industries about various benefits associated with aptamers, such as they are single-stranded DNA and RNA molecules that can selectively bind to a specific target and have numerous advantages over monoclonal antibodies, is expected to spur the market growth through 2028. These molecules bind with targets, including proteins, peptides, small molecules, toxins, carbohydrates, and even live cells. It can be created by a selection process from a large random sequence pool, and it can be used for both clinical and research purposes.

Growing Prevalence of Chronic and Rare Diseases

The growing prevalence of rare diseases requires new treatments with advanced characteristic features to fight against the viruses, which will enhance the demand for aptamers during the forecasted period. Similarly, continuous advancements in technologies are expected to drive the growth of the market. According to a research study by US Healthcare Agency published in Electrochimica Acta Journal in April 2022, the study results found that aptamers have come into the spotlight as bio-mimetic molecular recognition elements in the field of biomedicine due to various applications in diagnostics, drug delivery, therapeutics, and pharmaceutical analysis. Also, the development of new kits to detect cancer and other diseases increases the demand for aptamers in the forecasted period.

Market Segmentation

Global Aptamers market can be segmented by type, technology, application, end user, and by region. Based on type, the market can be segmented into DNA Aptamers, XNA Aptamers, and RNA Aptamers. Based on Technology, the market can be divided into SELEX, and Others. Based on application, the market can be differentiated into therapeutics development, research & development, diagnostics, and others. Based on end-user, the market can be grouped into pharmaceutical & biotechnology companies, academic & research institutions, contract research organizations, and others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America.

Recent Developments

• In March 2021, Aptamer Group, the developer of Optimer reagents, announced its merger with Mologic, which is a manufacturer of lateral flow and rapid diagnostic test kits. The merger was executed with an aim to manufacture testing kits for Novel Coronavirus, i.e., SARS-CoV-2.

• In May 2020, Portage Biotech made an additional investment in Saugatuck therapeutics after achieving proof of concept. This has triggered the next tranche of capital infusion of USD700,000. Saugatuck has been able to formulate a proprietary PD1 aptamer in the NLG formulation and has shown the formulation properly modulates PD1 signaling.

Market Players

Aptamer Group., Raptamer Discovery Group., Somalogic Inc., Aptamer Sciences, Inc., Aptagen LLC., Maravai Lifesciences., Kaneka Corporation., Neoventures Biotechnology Inc., and Aptus Biotech., Base Pair Biotechnologies. are some of the leading players operating in the Global Aptamers Market.

Report Scope

In this report, the Global Aptamers market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Aptamers Market, By Type:

• DNA Aptamers
• XNA Aptamers
• RNA Aptamers

Aptamers Market, By Technology:

• SELEX
• Others

Aptamers Market, By Application:

• Therapeutics Development
• Research & development
• Diagnostics
• Others

Aptamers Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions
• Contract Research Organizations
• Others

Aptamers Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Aptamers Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Aptamers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (DNA Aptamers, XNA Aptamers, RNA Aptamers)
  • 5.2.2. By Technology (SELEX, Others)
  • 5.2.3. By Application (Therapeutics Development, Research & Development, Diagnostics, Others)
  • 5.2.4. By End user (Pharmaceutical & Biotechnology Companies, Academic & Research Institutions, Contract Research Organizations, Others)
  • 5.2.5. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.6. By Company (2022)
• 5.3. Market Map
  • 5.3.1 By Type
  • 5.3.2 By Technology
  • 5.3.3 By Application
  • 5.3.4 By End user
  • 5.3.5 By Region

6. North America Aptamers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End user
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Aptamers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Aptamers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Aptamers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Aptamers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End user
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Aptamers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Aptamers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Aptamers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Aptamers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Aptamers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Aptamers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End user
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Aptamers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Aptamers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Aptamers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Aptamers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Aptamers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Aptamers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End user
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Aptamers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Aptamers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Aptamers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Aptamers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End user
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Aptamers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Aptamers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Aptamers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Aptamers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Aptamer Group
  • 15.6.2 Raptamer Discovery Group
  • 15.6.3 Somalogic Inc.
  • 15.6.4 Aptamer Sciences, Inc.
  • 15.6.5 Aptagen LLC.
  • 15.6.6 Maravai Lifesciences.
  • 15.6.7 Kaneka Corporation.
  • 15.6.8 Neoventures Biotechnology Inc.
  • 15.6.9 Aptus Biotech.
  • 15.6.10 Base Pair Biotechnologies.

16. Strategic Recommendations